Septerna Inc (SEPN)

02:30 AM

Septerna (NASDAQ:SEPN) Coverage Initiated at Wells Fargo & Company - Defense World

02:30 AM

02:30 AM

JPMorgan Chase & Co. Begins Coverage on Septerna (NASDAQ:SEPN) - Defense World

02:30 AM

02:30 AM

Septerna (NASDAQ:SEPN) Coverage Initiated at TD Cowen - Defense World

02:30 AM

Nov 20, 2024

Septerna started by J.P. Morgan at overweight, GPCR platform cited - MSN

Nov 20, 2024

Nov 20, 2024

Septerna, Inc. Reports Q3 2024 Financials and Progress - TipRanks

Nov 20, 2024

Nov 20, 2024

Septerna Shares Fall 7% After Wider 3Q Loss - MarketWatch

Nov 20, 2024

Nov 20, 2024

Septerna Reports Third Quarter 2024 Financial Results and Recent Business Highlights - The Manila Times

Nov 20, 2024

Nov 20, 2024

Septerna Advances Key Drug Trial, Reports $137.5M Cash Position After Successful IPO | SEPN Stock News - StockTitan

Nov 20, 2024

Nov 20, 2024

Septerna initiated with an Overweight at JPMorgan - Yahoo Finance

Nov 20, 2024

Nov 20, 2024

TD Cowen optimistic on Septerna stock as preclinical data fuels confidence - Investing.com Australia

Nov 20, 2024

Nov 20, 2024

JPMorgan bullish on Septerna stock—pipeline strategy drives optimism - Investing.com India

Nov 20, 2024

Nov 19, 2024

Septerna Poised For Biopharma Breakthrough: Analysts Cite GPCR Innovation And 2025 Milestones - AOL

Nov 19, 2024

Nov 19, 2024

Cantor launches Septerna stock coverage, highlighting platform value and growth in GPCR drug development - Investing.com

Nov 19, 2024

Nov 19, 2024

Septerna started by J.P. Morgan at overweight, GPCR platform cited (NASDAQ:SEPN) - Seeking Alpha

Nov 19, 2024

Nov 19, 2024

This Apollo Global Management Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga

Nov 19, 2024

Nov 19, 2024

Septerna (NASDAQ:SEPN) Now Covered by Cantor Fitzgerald - MarketBeat

Nov 19, 2024

Nov 19, 2024

Septerna (NASDAQ:SEPN) Earns Buy Rating from Analysts at TD Cowen - MarketBeat

Nov 19, 2024

Nov 19, 2024

JPMorgan Chase & Co. Initiates Coverage on Septerna (NASDAQ:SEPN) - MarketBeat

Nov 19, 2024

Nov 19, 2024

Wells Fargo & Company Initiates Coverage on Septerna (NASDAQ:SEPN) - MarketBeat

Nov 19, 2024

Nov 19, 2024

JPMorgan bullish on Septerna stock—pipeline strategy drives optimism By Investing.com - Investing.com Canada

Nov 19, 2024

Nov 05, 2024

RA Capital Management's Strategic Investment in Septerna Inc - GuruFocus.com

Nov 05, 2024

Nov 03, 2024

Buffett Still Building This Stake, Plus Huge Insider Buy in Biotech IPO - 24/7 Wall St.

Nov 03, 2024

Oct 31, 2024

Wednesday's Insider Activity: Top Buys and Sells in US Stocks By Investing.com - Investing.com Australia

Oct 31, 2024

Oct 31, 2024

Nasdaq debutante Septerna swells its IPO to $331m - pharmaphorum

Oct 31, 2024

Oct 31, 2024

Septerna (NASDAQ:SEPN) Files Amendment and Restatement of Certificate of Incorporation and Bylaws - Defense World

Oct 31, 2024

Oct 30, 2024

Septerna Announces Closing of $331.2 Million Upsized Initial Public Offering - ForexTV.com

Oct 30, 2024

Oct 30, 2024

Ra Capital Management buys $75 million in Septerna stock By Investing.com - Investing.com Australia

Oct 30, 2024

Oct 30, 2024

Ra Capital Management buys $75 million in Septerna stock - Investing.com

Oct 30, 2024

Oct 30, 2024

IPO Radar: Septerna, Swiggy and Horizon Robotics - The Armchair Trader

Oct 30, 2024

Oct 28, 2024

Septerna sees $11.7 million in stock purchases by Third Rock Ventures - Investing.com South Africa

Oct 28, 2024

Oct 28, 2024

IPO Roundup: Brazil Potash, Septerna and more (NYSEARCA:IPO) - Seeking Alpha

Oct 28, 2024

Oct 26, 2024

Septerna proposes terms for upsized $175M IPO - MSN

Oct 26, 2024

Oct 26, 2024

U.S. IPO Weekly Recap: Sizable Tech And Biotech IPOs Are Joined By A Flurry Of Small Names - Seeking Alpha

Oct 26, 2024

Oct 25, 2024

Septerna’s GPCRs draw strong demand in $288M IPO - BioCentury

Oct 25, 2024

Oct 25, 2024

Finance Watch: Septerna Raises $288m In Public Market Debut - Citeline

Oct 25, 2024

Oct 25, 2024

Hedge Funds, Asset Managers Turn Dollar Bulls on Election Risks - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

Septerna Shares Jump 19% After IPO Shows Biotech Still Hot - Bloomberg

Oct 25, 2024

Oct 25, 2024

Septerna Shares Rise 29% on First Trading Day - MarketWatch

Oct 25, 2024

Oct 25, 2024

Septerna’s Upsized IPO Brings In $288M to Support a Pipeline of GPCR Drugs - MedCity News

Oct 25, 2024

Oct 25, 2024

Septerna valued at $970 million as shares rise nearly 31% in Nasdaq debut - KFGO

Oct 25, 2024

Oct 25, 2024

Septerna Shares Jump 42% After IPO Shows Biotech Still Hot - AllSides

Oct 25, 2024

Oct 25, 2024

Goodwin, Cooley Guide Septerna's Upsized $288M IPO - Law360

Oct 25, 2024

Oct 25, 2024

Septerna's $288M IPO is another sign of the market warming to biotech investment - Fierce Biotech

Oct 25, 2024

Oct 25, 2024

Septerna Rings the Nasdaq Stock Market Opening Bell - Nasdaq

Oct 25, 2024

Oct 25, 2024

Septerna Rings the Opening Bell - Nasdaq

Oct 25, 2024

Oct 25, 2024

MicroStrategy Touches New Highs as Trading Volume Relative to Nvidia Surges - Yahoo Finance

Oct 25, 2024

Oct 25, 2024

Septerna Prices Upsized 16M Share IPO at $18/sh By Investing.com - Investing.com Nigeria

Oct 25, 2024

Oct 25, 2024

Septerna Prices Upsized 16M Share IPO at $18/sh - Investing.com

Oct 25, 2024

Oct 25, 2024

Septerna Shares Set for Trading Debut After Upsized IPO - MarketWatch

Oct 25, 2024